Search

Scott Stuart, Chair of the Boards of Trustees and Governing Trustees at Memorial Sloan Kettering Cancer Center (MSK), has been recognized as a Notable Nonprofit Board Leader in the 2023 Crain’s New York Business special editorial feature.

… Tuesday, October 10, 2023 Scott Stuart, Chair of the Boards of Trustees and Governing Trustees at Memorial Sloan Kettering Cancer Center (MSK), has been recognized as a Notable Nonprofit Board Leader in the 2023 Crain’s New York Business special editorial feature. This list honors exceptional nonprofit

Dr. Mara Sherman's lab at the Sloan Kettering Institute is “all pancreas, all the time.” Learn how her research program is illuminating interactions between cancer cells and the dense weave of fibrous cells that surrounds and protects pancreatic tumors.

… Monday, June 24, 2024 While the overall five-year survival rate for pancreatic cancer is slowly improving, it remains discouragingly low — just 13%, according to the American Cancer Society . And the odds are even worse if the cancer is discovered after it has spread to other organs. Dr. Mara Sherman

IBM, WellPoint, Inc., and Memorial Sloan Kettering Cancer Center today unveiled the first commercially developed Watson-based cognitive computing breakthroughs. These innovations stand alone to help transform the quality and speed of care delivered to patients through individualized, evidence-based medicine.

… Friday, February 8, 2013 IBM (NYSE: IBM ), WellPoint, Inc. (NYSE: WLP ), and Memorial Sloan Kettering Cancer Center today unveiled the first commercially developed Watson-based cognitive computing breakthroughs. These innovations stand alone to help transform the quality and speed of care delivered to

As 2017 draws to a close, take a look back at the scientific discoveries that deepened our understanding of cancer in the past year.

… Tuesday, December 5, 2017 This past year, Memorial Sloan Kettering researchers made important advances in basic and translational science that furthered our understanding of cancer and of how best to treat it. Here, we describe some of the year’s highlights. First CAR T Cell Therapies FDA Approved By

Scheduled to start in Summer 2025, this cohort program will facilitate tailored mentorship with MSK faculty, while providing insight into MSK's drug development resources and a pathway for future collaboration via the Accelerator.

… Wednesday, April 30, 2025 MSK recently announced the launch of a new cohort program in the MSK Therapeutics Accelerator . Scheduled to start in Summer 2025, this cohort program will facilitate tailored mentorship with MSK faculty, while providing insight into MSK’s drug development resources and a pathway

Research points to the role of a protein called MYB, which has long been known to play a role in cancer.

… Friday, February 5, 2021 Summary Research shows how a protein called MYB can be targeted, suggesting a new approach for drugs that could treat a range of cancers, especially myeloid leukemias in both children and adults. Disruption in the way genes turn on and off can cause tumors to grow and proliferate

New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute finds tumor-associated macrophages that express a specific transcription factor might be targeted to improve immunotherapy; examines how different mutational processes impact individual cell genomes in cancer; sheds new light on cell senescence in cancer; and offers new models to aid the search for new treatments for mesothelioma.

… Wednesday, November 23, 2022 New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute — MSK’s experimental research arm — finds tumor-associated macrophages that express a specific transcription factor might be targeted to improve immunotherapy; examines how different

This research is important for developing better drugs and screening methods for pancreatic tumors.

… Monday, September 3, 2018 Summary Understanding how pancreatic cancer develops is important for developing better drugs and screening methods. Researchers are finding new clues by studying abnormal pancreas cells that sometimes turn into cancer. One universal truth about cancer is that the later it’s

On Feburary 6, teams of Gerstner Sloan Kettering students and faculty joined 2,500 indoor cyclists from New York and Chicago to raise more than $2.4 million to support rare cancer research at Memorial Sloan Kettering Cancer Center.

… Saturday, February 20, 2010 On February 6, teams of Gerstner Sloan Kettering students and faculty joined 2,500 indoor cyclists from New York and Chicago to raise more than $2.4 million to support rare cancer research at Memorial Sloan Kettering Cancer Center. The event, Cycle for Survival , was founded

MSK researchers discover that the body senses and attacks harmful bacteria indirectly after the pathogens cause stress within the cells.

… Tuesday, October 21, 2014 Summary MSK researchers discover that the body senses and attacks harmful bacteria indirectly after the pathogens cause stress within the cells. Bacterial infections can cause major problems for people undergoing treatment for cancer and other diseases. The concern is especially